iTAD: Internet-delivered Transdiagnostic Intervention for Anxiety and Depression

Sponsor
West University of Timisoara (Other)
Overall Status
Unknown status
CT.gov ID
NCT02739607
Collaborator
(none)
100
1
2
11
9.1

Study Details

Study Description

Brief Summary

Objectives

  1. To test the effectiveness and acceptability of an augmented internet-supported transdiagnostic intervention in Romania.

  2. To assess the cost-effectiveness of the Internet version of the transdiagnostic program as compared to a standard treatment/usual care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Transdiagnostic program
N/A

Detailed Description

The effectiveness of a transdiagnostic intervention will be compared with a wait list control group using a randomized control trial (RCT) design in a culture where this has not been tested before. The treatment approach is mainly emotion-focus, teaching participants how to confront and experience uncomfortable emotions, and how more adaptive coping mechanisms could be used. Because internet-delivered interventions represent an effective way to disseminate evidence-based programs, investigators decided to present our intervention online.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Internet-delivered Transdiagnostic Intervention for Anxiety and Depression in Romania- A Randomized Control Trial
Study Start Date :
Apr 1, 2016
Anticipated Primary Completion Date :
Sep 1, 2016
Anticipated Study Completion Date :
Mar 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Transdiagnostic program

This arm represents the Transdiagnostic intervention program for emotional disorders. The intervention, based on the Cognitive Behavioral Therapy (CBT) principles, is designed to encourage participants to confront and experience uncomfortable emotions, and use adaptive coping mechanisms.

Behavioral: Transdiagnostic program
This transdiagnostic program is based on the general Cognitive Behavioral Therapy (CBT) principles and targets core higher order factors such as negative affectivity and emotion dysregulation, using common intervention techniques applicable across disorders. The program was designed to directly address the aversive emotional experiences often reported by clients, hoping to reverse participants' maladaptive thinking style and dysfunctional behaviors.

No Intervention: Wait list control group

This arm represents the wait-list comparison group.

Outcome Measures

Primary Outcome Measures

  1. Penn State Worry Questionnaire (PSWQ) [Absolute values (average score) of PSWQ at 11 weeks (post-intervention)]

    The PSWQ was designed to measure participant's level of generalized anxiety or worry. The scale is unidimensional and the total score rages from 16 to 80. Low scores are associated with low levels of worry, while high scores are associated with high levels of worry.

  2. Social Phobia Inventory (SPIN) [Absolute values (average score) of SPIN at 11 weeks (post-intervention)]

    The SPIN was designed to measure participant's level of social phobia. The scale is unidimensional and the total score rages from 0 to 68. Low scores are associated with low levels of social phobia, while high scores are associated with high levels of social phobia.

  3. Yale-Brown Obsessive Compulsive Scale (YBOCS) [Absolute values (average score) of YBOCS at 11 weeks (post-intervention)]

    The YBOCS was designed to measure participant's level of obsessions and compulsions (O&C). The scale total score rages from 0 to 40. Low scores are associated with low levels of O&C, while high scores are associated with high levels of O&C.

  4. Panic Disorder Severity Scale - Self Report (PDSS-SR) [Absolute values (average score) of PDSS-SR at 11 weeks (post-intervention)]

    The PDSS-SR was designed to measure participant's level of panic. The scale is unidimensional and the total score rages from 0 to 28. Low scores are associated with low levels of panic, while high scores are associated with high levels of panic.

  5. Post-Traumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual-5 (PCL-5) [Absolute values (average score) of PCL-5 at 11 weeks (post-intervention)]

    The PCL-5 was designed to measure participant's level of post-traumatic stress. The scale is unidimensional and the total score rages from 0 to 80. Low scores are associated with low levels of post-traumatic stress, while high scores are associated with high levels of post-traumatic stress.

  6. Beck Depression Inventory-II (BDI-II) [Absolute values (average score) of BDI-II at 11 weeks (post-intervention)]

    The Beck Depression Inventory-II (BDI-II) was designed to measure participant's level of depression. The scale is unidimensional and the total score rages from 0 to 63. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.

Secondary Outcome Measures

  1. Emotion Regulation Questionnaire (ERQ) [Absolute values (average score) of ERQ at 11 weeks (post-intervention)]

    The ERQ was designed to measure participant's level of emotion regulation. The scale is multidimensional and measures two emotion regulation strategies: reappraisal and suppression. Low scores are associated with low levels of emotion regulation, while high scores are associated with high levels of emotion regulation.

  2. Anxiety Sensitivity Index (ASI) [Absolute values (average score) of ASI at 11 weeks (post-intervention)]

    The ASI was designed to measure participant's level of anxiety sensitivity. The scale is unidimensional and the total score rages from 0 to 64. Low scores are associated with low levels of anxiety sensitivity, while high scores are associated with high levels of anxiety sensitivity.

  3. Beck Anxiety Inventory (BAI) [Absolute values (average score) of Treatment satisfaction and acceptability at 11 weeks (post-intervention)]

    The BAI was designed to measure participant's level of anxiety. The scale is unidimensional and the total score rages from 0 to 63. Low scores are associated with low levels of anxiety, while high scores are associated with high levels of anxiety.

  4. Almost Perfect Scale-Revised (APS-R) [Absolute values (average score) of APS-R at 11 weeks (post-intervention)]

    The APS-R was designed to measure participant's level of perfectionism. The scale is multidimensional and measures three dimensions of perfectionism: high standards, order and discrepancy. Low scores are associated with low levels of perfectionism, while high scores are associated with high levels of perfectionism.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • be fluent in Romanian

  • be over 18 years

  • have the principal diagnostic of generalized anxiety disorder and/or obsessive-compulsive disorder and/or panic disorder and/or social anxiety disorder and/or major depression disorder and/or dysthymia (or any combination of these diagnostics) on Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disorders (SCID-I)

  • have access to an Internet connected computer

Exclusion Criteria:
  • suicidal ideation

  • ongoing psychological treatment for generalized anxiety disorder and/or obsessive-compulsive disorder and/or panic disorder and/or social anxiety disorder and/or major depression disorder and/or dysthymia

  • other primary disorder that need treatment

  • obstacle to participation (i.e., long travel plans)

  • recent change in psychiatric medication (i.e., during the last 6 weeks)

Contacts and Locations

Locations

Site City State Country Postal Code
1 West University of Timisoara Timișoara Timiș Romania 300223

Sponsors and Collaborators

  • West University of Timisoara

Investigators

  • Study Director: Bogdan T Tulbure, PhD, West University of Timisoara

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
West University of Timisoara
ClinicalTrials.gov Identifier:
NCT02739607
Other Study ID Numbers:
  • WUTimisoara-iTAD
First Posted:
Apr 15, 2016
Last Update Posted:
May 6, 2016
Last Verified:
May 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by West University of Timisoara
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2016